Results 81 to 90 of about 51,741 (305)

Six-Month Follow-Up of Immune Responses after a Rapid Mass Vaccination against SARS-CoV-2 with BNT162b2 in the District of Schwaz/Austria. [PDF]

, 2022
In response to a large outbreak of the SARS-CoV-2 Beta (B.1.351) variant in the district Schwaz, Austria, a rapid mass vaccination campaign with BNT162b2 was carried out in spring 2021, immunizing more than 70% of the adult population within one week ...

core   +2 more sources

Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2

Nature, 2021
Although two-dose mRNA vaccination provides excellent protection against SARS-CoV-2, there is little information about vaccine efficacy against variants of concern (VOC) in individuals above eighty years of age1.
D. Collier, I. Ferreira, Prasanti Kotagiri, R. Datir, E. Lim, E. Touizer, B. Meng, A. Abdullahi, Stephen Gordon Christoph Nathalie Paul J. Paul A. Nicholas Baker Dougan Hess Kingston Lehner Lyons Matheson O, Stephen Gordon Christoph Nathalie Paul J. Paul A. Nicholas Baker Dougan Hess Kingston Lehner Lyons Matheson O, Stephen Baker, G. Dougan, C. Hess, N. Kingston, P. Lehner, Paul A. Lyons, Nicholas J Matheson, Willem H. Owehand, C. Saunders, C. Summers, James E. D. Thaventhiran, M. Toshner, M. Weekes, P. Maxwell, A. Shaw, Ashlea Jo Laura Jason Anne Stewart Julie Sarah Jane Sherl Bucke Calder Canna Domingo Elmer Fuller Harris Hew, Ashlea Bucke, J. Calder, L. Canna, Jason Domingo, A. Elmer, S. Fuller, Julie Harris, S. Hewitt, J. Kennet, Sherly Jose, Jenny Kourampa, A. Meadows, Criona O’Brien, Jane Price, Cherry Publico, Rebecca J Rastall, C. Ribeiro, J. Rowlands, Valentina Ruffolo, Hugo Tordesillas, Ben Benjamin J. Stuart Stefan Josh Christopher Kelvin Bullman Dunmore Fawke Gräf Hodgson Huang Hunter Jo, Ben Bullman, B. Dunmore, Stuart Fawke, S. Gräf, J. Hodgson, Christopher Huang, K. Hunter, E. Jones, E. Legchenko, C. Matara, Jennifer M Martin, F. Mescia, Ciara O’Donnell, L. Pointon, Nicole Pond, J. Shih, R. Sutcliffe, T. Tilly, C. Treacy, Z. Tong, Jennifer Wood, Marta Wylot, Laura Ariana Georgie Chiara Aloka Madeline Stuart Nick R Bergamaschi Betancourt Bower Cossetti De Sa Epping, L. Bergamaschi, Ariana Betancourt, G. Bower, C. Cossetti, Aloka De Sa, M. Epping, Stuart Fawke, Nicholas S. Gleadall, R. Grenfell, Andrew Hinch, O. Huhn, Sarah E. Jackson, Isobel Jarvis, Ben Krishna, Dan Lewis, J. Marsden, Francesca L. Nice, G. Okecha, Ommar Omarjee, Marianne R Perera, Martin Potts, N. Richoz, V. Romashova, N. S. Yarkoni, Rahul Sharma, L. Stefanucci, J. Stephens, Mateusz Strezlecki, L. Turner, Eckart M. Katherine Masa Michael Alice Sabrina Mayurun Sa D. D. De Bie Bunclark Josipovic Mackay Michael Ros, Eckart M. D. D. De Bie, K. Bunclark, Maša Josipović, Michael Mackay, A. Michael, Sabrina Rossi, Mayurun Selvan, Sarah Spencer, Cissy Yong, Ali Alice Lucy Caroline Gary Ansaripour Michael Mwaura Patterson Polwarth, A. Ansaripour, L. Mwaura, C. Patterson, Gary Polwarth, Petra Giovanni Polgarova di Stefano, P. Polgarova, Giovanni Di Stefano, Codie Rachel Fahey Michel, Codie Fahey, R. Michel, Sze-How Jerome D. Elaine Bong Coudert Holmes, Sze-How Bong, J. Coudert, Elaine Holmes, John Helen Daniela Debbie Eleanor Anita Barbara Jennife Allison Butcher Caputo Clapham-Riley Dewhurst Furl, J. Allison, H. Butcher, D. Caputo, Debbie Clapham-Riley, Eleanor F. Dewhurst, A. Furlong, B. Graves, J. Gray, Tasmin Ivers, Mary A. Kasanicki, Emma Le Gresley, R. Linger, Sara E. Meloy, Frances E. Muldoon, Nigel R. Ovington, S. Papadia, Isabel Phelan, H. Stark, K. Stirrups, P. Townsend, Neil E. Walker, J. Webster, A. Elmer, N. Kingston, B. Graves, Emma Le Gresley, D. Caputo, L. Bergamaschi, Kenneth G. C. Smith, J. Bradley, L. Ceron-Gutierrez, P. Cortes-Acevedo, G. Barcenas-Morales, M. Linterman, Laura E. McCoy, Chris Davis, E. Thomson, Paul A. Lyons, E. McKinney, R. Doffinger, M. Wills, Ravindra K. Gupta   +166 more
semanticscholar   +1 more source

SARS-CoV-2 S-RBD IgG & Neutralizing antibodies among different categories of health care workers post third dose BNT162b2 mRNA COVID-19 vaccine

Human Vaccines & Immunotherapeutics, 2023
Neutralizing antibodies (NTAb) play a significant role in preventing and protecting against SARS-CoV-2 virus infection. Identifying NTAb is undoubtedly imperative in understanding the immunity toward COVID-19 better.
Wan Muhammad Azfar Wan Shuaib, Izzatul Aliaa Badaruddin, Munirah Mansor, Sharifah Azura Salleh, Mohd Rohaizat Hassan, Steward Lindong, Shahril Nizam Samad, Hanita Othman   +7 more
doaj   +1 more source

Safety and efficacy of RNA vaccines: State of the art

Медицинская иммунология, 2021
This review describes principles of action and the method of delivery of mRNA molecules into cells, as well as some of developed RNA vaccines and the results obtained in their study, though they have not been authorized for use yet.
A. V. Blagov, A. A. Bukaeva, V. V. Makarov, Z. V. Bochkaeva   +3 more
doaj   +1 more source

Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK [PDF]

, 2021
The effectiveness of the BNT162b2 and ChAdOx1 vaccines against new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections requires continuous re-evaluation, given the increasingly dominant B.1.617.2 (Delta) variant.
Bell, J, Cook, D, Crook, D, Diamond, I, Eyre, DW, Farrar, J, Hay, J, House, T, Matthews, PC, Newton, JN, Peto, TEA, Pouwels, KB, Pritchard, E, Rourke, E, Stoesser, N, Studley, R, Vihta, K-D, Walker, AS   +17 more
core  

Early antibody response in healthcare professionals after two doses of SARS-CoV-2 mRNA vaccine (BNT162b2) [PDF]

, 2021
Data on the immune response after two doses of BNT162b2 are so far limited. Previously infected individuals were excluded from pivotal clinical trials and the optimal dose regimen in this population has not been clearly studied.
Bayart, Jean-Louis, Closset, Mélanie, Dogné, Jean-Michel, Douxfils, Jonathan, Favresse, Julien, Mullier, François   +5 more
core   +1 more source

The Influence of Two Priming Doses of Different Anti-COVID-19 Vaccines on the Production of Anti-SARS-CoV-2 Antibodies After the Administration of the Pfizer/BioNTech Booster

Infection and Drug Resistance, 2022
Blanka Wolszczak Biedrzycka,1,2 Anna Bieńkowska,1,2 Elwira Smolińska-Fijołek,3 Grzegorz Biedrzycki,4 Justyna Dorf5 1Department of Psychology and Sociology of Health and Public Health, University of Warmia and Mazury in Olsztyn ...
Wolszczak Biedrzycka B, Bieńkowska A, Smolińska-Fijołek E, Biedrzycki G, Dorf J   +4 more
doaj  

Adverse Reactions after BNT162b2 Messenger RNA Vaccination for Coronavirus Disease 2019 in Healthcare Workers Compared with Influenza Vaccination

Vaccines, 2023
This study aimed to compare adverse reactions following BNT162b2 and influenza vaccinations in healthcare workers. This study included healthcare workers who received the BNT162b2 vaccine and/or inactivated influenza vaccine, quadrivalent (IIV4), on 18 ...
A-Sol Kim, Sung-Min Kim, Ji-Eun Song, Soyoon Hwang, Eunkyung Nam, Ki Tae Kwon   +5 more
doaj   +1 more source

Comparing self-reported reactogenicity between adolescents and adults following the use of BNT162b2 (Pfizer-BioNTech) messenger RNA Covid-19 vaccine: a prospective cohort study [PDF]

, 2022
Objectives: Although clinical data have shown that the BNT162b2 vaccine, which is widely used in many countries, is safe and effective as a protection against the SARS-CoV-2 infection, extant research in adverse reactions using real-world data of ...
Chan, EWW, Chan, EWY, Chui, CSL, Ip, P, Lai, FTT, Lau, LKW, Leung, J, Leung, MTY, Li, X, Lum, D, Wan, EYF, Wong, CKH, Wong, ICK, Wong, RSM   +13 more
core   +1 more source

Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination

Nature Medicine, 2021
Currently approved viral vector-based and mRNA-based vaccine approaches against coronavirus disease 2019 (COVID-19) consider only homologous prime-boost vaccination.
Joana Barros-Martins, S. Hammerschmidt, A. Cossmann, Iva Odak, M. Stankov, Gema Morillas Ramos, A. Dopfer-Jablonka, Annika Heidemann, C. Ritter, Michaela Friedrichsen, Christian R. Schultze-Florey, I. Ravens, S. Willenzon, Anja Bubke, Jasmin Ristenpart, Anika Janssen, G. Ssebyatika, G. Bernhardt, J. Münch, M. Hoffmann, S. Pöhlmann, T. Krey, B. Bošnjak, R. Förster, G. Behrens   +24 more
semanticscholar   +1 more source